More heart failure patients will be taking an aldosterone antagonist

More heart failure patients will be taking an aldosterone antagonist...spironolactone or the new Inspra (eplerenone).

Spironolactone improves survival in patients with severe heart failure and reduced left ventricular function.

Inspra improves survival in patients who've had a heart attack and who also have decreased heart function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote